HUE060275T2 - Hatóanyaggal való visszaélés és addikció kezelésére alkalmas oxadiazaspiro-vegyületek - Google Patents
Hatóanyaggal való visszaélés és addikció kezelésére alkalmas oxadiazaspiro-vegyületekInfo
- Publication number
- HUE060275T2 HUE060275T2 HUE16797458A HUE16797458A HUE060275T2 HU E060275 T2 HUE060275 T2 HU E060275T2 HU E16797458 A HUE16797458 A HU E16797458A HU E16797458 A HUE16797458 A HU E16797458A HU E060275 T2 HUE060275 T2 HU E060275T2
- Authority
- HU
- Hungary
- Prior art keywords
- addiction
- treatment
- drug abuse
- oxadiazaspiro
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Addiction (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15382566 | 2015-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE060275T2 true HUE060275T2 (hu) | 2023-02-28 |
Family
ID=54707728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE16797458A HUE060275T2 (hu) | 2015-11-16 | 2016-11-15 | Hatóanyaggal való visszaélés és addikció kezelésére alkalmas oxadiazaspiro-vegyületek |
Country Status (30)
Country | Link |
---|---|
US (2) | US10927128B2 (hu) |
EP (1) | EP3377500B1 (hu) |
JP (1) | JP6884974B2 (hu) |
KR (1) | KR20180080327A (hu) |
CN (1) | CN108349999A (hu) |
AR (1) | AR106697A1 (hu) |
AU (1) | AU2016356488B2 (hu) |
BR (1) | BR112018009279A8 (hu) |
CA (1) | CA3002286A1 (hu) |
CO (1) | CO2018004665A2 (hu) |
DK (1) | DK3377500T3 (hu) |
ES (1) | ES2932000T3 (hu) |
HR (1) | HRP20221343T1 (hu) |
HU (1) | HUE060275T2 (hu) |
IL (1) | IL259035B (hu) |
LT (1) | LT3377500T (hu) |
MA (1) | MA43250B1 (hu) |
MX (1) | MX2018005439A (hu) |
MY (1) | MY193423A (hu) |
PH (1) | PH12018500814A1 (hu) |
PL (1) | PL3377500T3 (hu) |
PT (1) | PT3377500T (hu) |
RS (1) | RS63734B1 (hu) |
SG (1) | SG11201803153RA (hu) |
SI (1) | SI3377500T1 (hu) |
TN (1) | TN2018000122A1 (hu) |
TW (1) | TWI756196B (hu) |
UA (1) | UA123775C2 (hu) |
WO (1) | WO2017084752A1 (hu) |
ZA (1) | ZA201802845B (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI756196B (zh) | 2015-11-16 | 2022-03-01 | 西班牙商艾斯提夫製藥股份有限公司 | 用於治療藥物濫用和成癮之氧雜二氮雜螺環化合物 |
WO2020157026A1 (en) * | 2019-01-28 | 2020-08-06 | Esteve Pharmaceuticals, S.A. | Hydroxylated derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain |
AU2022346825A1 (en) | 2021-09-20 | 2024-03-07 | Esteve Pharmaceuticals, S.A. | Oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4244961A (en) * | 1978-10-26 | 1981-01-13 | Syntex (U.S.A.) Inc. | 1-Oxa-3,8-diazaspiro[4.5]decan-2-ones antihypertensive agents |
US4332804A (en) | 1981-03-23 | 1982-06-01 | Syntex (U.S.A.) Inc. | 9-[2-(3-Indolyl)ethyl]-1oxa-4,9-diazaspiro[5.5]undecan-3-ones |
US4353901A (en) * | 1981-10-19 | 1982-10-12 | Syntex (U.S.A.) Inc. | 9-(1,4-Benzodioxan-2-ylalkyl and hydroxyalkyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-ones |
US4353900A (en) | 1981-10-19 | 1982-10-12 | Syntex (U.S.A.) Inc. | 9-(Arylalkyl or aroylalkyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones |
US6114541A (en) | 1997-03-10 | 2000-09-05 | Hoffmann-La Roche Inc. | Method for the preparation of α-Bromo-Lactam derivatives |
CA2554671A1 (en) * | 2004-02-10 | 2005-08-18 | F.Hoffmann-La Roche Ag | Chemokine ccr5 receptor modulators |
DE602005025979D1 (de) | 2004-03-03 | 2011-03-03 | Vital Health Sciences Pty Ltd | Alkaloid-formulierungen |
EP1634873A1 (en) | 2004-08-27 | 2006-03-15 | Laboratorios Del Dr. Esteve, S.A. | Sigma receptor inhibitors |
JP5135795B2 (ja) * | 2004-08-27 | 2013-02-06 | 小野薬品工業株式会社 | 塩基性基を含有する化合物およびその用途 |
CN101228127B (zh) | 2005-05-30 | 2012-05-16 | Msdk.K.公司 | 哌啶衍生物 |
CN101203567A (zh) * | 2005-06-07 | 2008-06-18 | 西巴特殊化学品控股有限公司 | 抗刮擦聚烯烃 |
DE102005030051A1 (de) | 2005-06-27 | 2006-12-28 | Grünenthal GmbH | Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln |
JP5323485B2 (ja) | 2005-10-19 | 2013-10-23 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 新規バニロイド受容体リガンド及医薬の製造へのその使用 |
PT1961744E (pt) | 2005-11-18 | 2013-05-15 | Ono Pharmaceutical Co | Composto que contém um grupo básico e sua utilização |
EP1829869A1 (en) | 2006-03-02 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
EP1847542A1 (en) | 2006-04-21 | 2007-10-24 | Laboratorios del Dr. Esteve S.A. | Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor |
AU2008219980B2 (en) | 2007-03-01 | 2012-01-12 | Mitsubishi Tanabe Pharma Corporation | Benzimidazole compound and pharmaceutical use thereof |
EP1982714A1 (en) | 2007-04-16 | 2008-10-22 | Laboratorios del Dr. Esteve S.A. | Pyrano-pyrazole-amines |
EP2020414A1 (en) | 2007-06-20 | 2009-02-04 | Laboratorios del Dr. Esteve S.A. | spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
JP2010538003A (ja) | 2007-08-29 | 2010-12-09 | グラクソスミスクライン エルエルシー | チアゾールおよびオキサゾールキナーゼ阻害薬 |
EP2070933A1 (en) | 2007-12-07 | 2009-06-17 | Laboratorios del Dr. Esteve S.A. | Tricyclic triazolic compounds |
ES2394547T3 (es) | 2008-02-06 | 2013-02-01 | Astrazeneca Ab | Compuestos |
EP2108643A1 (en) * | 2008-04-10 | 2009-10-14 | Laboratorios Del. Dr. Esteve, S.A. | 4-methyl-4, 5-dihydro-1H-pyrazole-3-carboxamide useful as a cannabinoid CB1 neutral antagonist |
GB201016912D0 (en) * | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
CN103517910B (zh) | 2011-03-14 | 2016-12-14 | 沃泰克斯药物股份有限公司 | 作为离子通道调节剂的吗啉-螺环哌啶酰胺 |
GB201107985D0 (en) | 2011-05-13 | 2011-06-29 | Astrazeneca Ab | Process |
WO2013052716A1 (en) * | 2011-10-07 | 2013-04-11 | Glaxosmithkline Llc | Fatty acid synthase inhibitors |
JPWO2013115294A1 (ja) | 2012-01-31 | 2015-05-11 | 東レ株式会社 | ジアザスピロウレア誘導体及びその医薬用途 |
US9751881B2 (en) | 2013-07-31 | 2017-09-05 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
TW201615642A (zh) | 2014-06-02 | 2016-05-01 | 伊史帝夫博士實驗室股份有限公司 | 具有多重模式抗疼痛活性的1-氧雜-4,9-二氮雜螺十一烷化合物之醯胺衍生物 |
TWI685497B (zh) * | 2014-06-02 | 2020-02-21 | 西班牙商伊史帝夫製藥公司 | 具有多重模式抗疼痛活性的1-氧雜-4,9-二氮雜螺十一烷化合物之烷基衍生物 |
TW201615643A (zh) * | 2014-06-02 | 2016-05-01 | 伊史帝夫博士實驗室股份有限公司 | 具有多重模式抗疼痛活性之1-氧雜-4,9-二氮雜螺十一烷化合物之烷基與芳基衍生物 |
US10513518B2 (en) * | 2015-01-29 | 2019-12-24 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
TWI756196B (zh) | 2015-11-16 | 2022-03-01 | 西班牙商艾斯提夫製藥股份有限公司 | 用於治療藥物濫用和成癮之氧雜二氮雜螺環化合物 |
-
2016
- 2016-11-15 TW TW105137236A patent/TWI756196B/zh active
- 2016-11-15 AU AU2016356488A patent/AU2016356488B2/en active Active
- 2016-11-15 CA CA3002286A patent/CA3002286A1/en active Pending
- 2016-11-15 JP JP2018524257A patent/JP6884974B2/ja active Active
- 2016-11-15 EP EP16797458.3A patent/EP3377500B1/en active Active
- 2016-11-15 PL PL16797458.3T patent/PL3377500T3/pl unknown
- 2016-11-15 HR HRP20221343TT patent/HRP20221343T1/hr unknown
- 2016-11-15 KR KR1020187017092A patent/KR20180080327A/ko not_active Application Discontinuation
- 2016-11-15 SI SI201631621T patent/SI3377500T1/sl unknown
- 2016-11-15 MY MYPI2018701503A patent/MY193423A/en unknown
- 2016-11-15 RS RS20221052A patent/RS63734B1/sr unknown
- 2016-11-15 DK DK16797458.3T patent/DK3377500T3/da active
- 2016-11-15 ES ES16797458T patent/ES2932000T3/es active Active
- 2016-11-15 SG SG11201803153RA patent/SG11201803153RA/en unknown
- 2016-11-15 HU HUE16797458A patent/HUE060275T2/hu unknown
- 2016-11-15 MX MX2018005439A patent/MX2018005439A/es unknown
- 2016-11-15 UA UAA201806353A patent/UA123775C2/uk unknown
- 2016-11-15 LT LTEPPCT/EP2016/001907T patent/LT3377500T/lt unknown
- 2016-11-15 WO PCT/EP2016/001907 patent/WO2017084752A1/en active Application Filing
- 2016-11-15 BR BR112018009279A patent/BR112018009279A8/pt active IP Right Grant
- 2016-11-15 MA MA43250A patent/MA43250B1/fr unknown
- 2016-11-15 PT PT167974583T patent/PT3377500T/pt unknown
- 2016-11-15 TN TNP/2018/000122A patent/TN2018000122A1/en unknown
- 2016-11-15 AR ARP160103486A patent/AR106697A1/es unknown
- 2016-11-15 US US15/774,407 patent/US10927128B2/en active Active
- 2016-11-15 CN CN201680066748.9A patent/CN108349999A/zh active Pending
-
2018
- 2018-04-16 PH PH12018500814A patent/PH12018500814A1/en unknown
- 2018-04-30 ZA ZA2018/02845A patent/ZA201802845B/en unknown
- 2018-04-30 IL IL259035A patent/IL259035B/en active IP Right Grant
- 2018-04-30 CO CONC2018/0004665A patent/CO2018004665A2/es unknown
-
2020
- 2020-12-21 US US17/128,738 patent/US11649248B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL258931A (en) | Medicinal compounds and methods | |
HK1247614A1 (zh) | 治療化合物及其用途 | |
IL266674A (en) | Preparations and methods for treating an opioid overdose | |
HK1258276A1 (zh) | 用於治療hiv的化合物和組合 | |
IL262825A (en) | Tetrahydropyridine and tetrahydropyrimidine substances, preparations containing them and their use for pain treatment | |
ZA201606322B (en) | Methods for acute and long-term treatment of drug addiction | |
GB201608885D0 (en) | Treatment | |
HK1248697A1 (zh) | 治療化合物及其用途 | |
ZA201802256B (en) | Compounds and therapeutic uses thereof | |
GB201617064D0 (en) | Compounds and their therapeutic use | |
IL270011B (en) | Medicinal compounds and methods | |
GB201504387D0 (en) | Materials and methods for the treatment of vascular disease | |
ZA201802845B (en) | Oxadiazaspiro compounds for the treatment of drug abuse and addiction | |
HK1255695A1 (zh) | 用於治療眼瞼下垂的組合物和方法 | |
LT3500572T (lt) | Citizino dariniai, skirti priklausomybių gydymui | |
IL266866A (en) | A drug to treat ***e addiction or prevent its relapse | |
HK1257593A1 (zh) | 治療糖尿病的新藥物及其用途 | |
IL260091A (en) | Composition and a method of treatment of the physical addiction | |
GB201608599D0 (en) | Treatment of opioid tollerence | |
GB201617107D0 (en) | Treatment | |
GB201613350D0 (en) | Treatment of hyperpigmentation | |
GB201612260D0 (en) | Treatment | |
GB201612193D0 (en) | Treatment | |
GB201609683D0 (en) | Treatment | |
GB201523012D0 (en) | The combination of chinese medicine for treating infantile cough |